Insider Transactions in Q3 2025 at Age X Therapeutics, Inc. (AGE)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 26
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
45,632
-100.0%
|
$319,424
$7.01 P/Share
|
|
Aug 26
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
45,632
+50.0%
|
$0
$0.06 P/Share
|
|
Aug 25
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,042
-100.0%
|
$10,210
$5.65 P/Share
|
|
Aug 25
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,042
+50.0%
|
$0
$0.06 P/Share
|
|
Aug 20
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,077
-100.0%
|
$10,385
$5.1 P/Share
|
|
Aug 20
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,077
+50.0%
|
$0
$0.06 P/Share
|
|
Aug 18
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,227
-100.0%
|
$11,135
$5.25 P/Share
|
|
Aug 18
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,227
+50.0%
|
$0
$0.06 P/Share
|
|
Aug 12
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,500
-100.0%
|
$27,500
$5.25 P/Share
|
|
Aug 12
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+50.0%
|
$0
$0.06 P/Share
|
|
Aug 04
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,500
-100.0%
|
$27,500
$5.17 P/Share
|
|
Aug 04
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+50.0%
|
$0
$0.06 P/Share
|
|
Jul 29
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,196
-100.0%
|
$25,176
$6.5 P/Share
|
|
Jul 29
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,196
+50.0%
|
$0
$0.06 P/Share
|
|
Jul 28
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,500
-100.0%
|
$32,500
$5.89 P/Share
|
|
Jul 28
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+50.0%
|
$0
$0.06 P/Share
|
|
Jul 21
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,500
-100.0%
|
$32,500
$5.34 P/Share
|
|
Jul 21
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+50.0%
|
$0
$0.06 P/Share
|
|
Jul 14
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,500
-100.0%
|
$32,500
$5.01 P/Share
|
|
Jul 14
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+50.0%
|
$0
$0.06 P/Share
|
|
Jul 07
2025
|
Randall Moreadith Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,500
-100.0%
|
$32,500
$5.67 P/Share
|
|
Jul 07
2025
|
Randall Moreadith Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500
+50.0%
|
$0
$0.06 P/Share
|